Secretory leukocyte protease inhibitor (SLPI) as a key factor for cholangiocarcinoma progression

被引：0
|
作者：
Phimsen, Suchada [1 ]
Chueajedton, Kangsadan [1 ]
Chueaiphuk, Chaiwat [1 ]
Jantra, Jeranan [1 ]
Sonsuwan, Anisa [1 ]
Kaewkong, Worasak [1 ]
Kumphune, Sarawut [1 ]
Wongkham, Sopit [1 ,2 ]
机构：
[1] Naresuan Univ, Dept Biochem, Fac Med Sci, Phitsanulok, Thailand
[2] Khon Kaen Univ, Cholangiocarcinoma Res Inst, Fac Med, Khon Kaen, Thailand
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2067
引用
收藏
页码：1092 / 1092
页数：1
相关论文
共 50 条
  • [21] Targeting CNS-Autoimmunity and -Repair Using the Secretory Leukocyte Protease Inhibitor (SLPI)
    Mueller, Andre M.
    Dinzey, Jacqueline
    Pedre, Xiomara
    Steinbrecher, Andreas
    Sadiq, Saud A.
    NEUROLOGY, 2009, 72 (11) : A420 - A421
  • [22] Identification of the secretory leukocyte protease inhibitor (SLPI) as a target of IRF-1 regulation
    Nguyen, H
    Teskey, L
    Lin, RT
    Hiscott, J
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 332 - 332
  • [23] Expression of Secretory Leukocyte Protease Inhibitor (SLPI) Detected by Immunohistochemistry in Hepatocellular and Cholangiocellular Tumours
    Ong, D. J.
    Hall, A.
    Triantafyllou, E.
    Pop, O.
    Thursz, M.
    Luong, T.
    Quaglia, A.
    JOURNAL OF PATHOLOGY, 2019, 249 : S45 - S45
  • [24] Anti-HIV activity of newly cloned secretory leukocyte protease inhibitor (SLPI)
    Konopka, K
    Shine, NR
    Wang, SC
    Düzgünes, N
    Whitman, CP
    ANTIVIRAL RESEARCH, 2003, 57 (03) : A47 - A47
  • [25] Identification of the secretory leukocyte protease inhibitor (SLPI) as a target of IRF-1 regulation
    Nguyen, H
    Teskey, L
    Lin, RT
    Hiscott, J
    ONCOGENE, 1999, 18 (39) : 5455 - 5463
  • [26] Temporal Induction of Secretory Leukocyte Protease Inhibitor (SLPI) in Odontoblasts by Lipopolysaccharide and Wound Infection
    Choi, Baik-Dong
    Jeong, Soon-Jeong
    Wang, Guanlin
    Kim, Heung-Joong
    Kim, Byung-Ock
    Hwang, Ho-Keel
    Lim, Do-Seun
    Kim, Sook-Hyang
    Jeong, Moon-Jin
    JOURNAL OF ENDODONTICS, 2009, 35 (07) : 997 - 1002
  • [27] Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome
    Dickey, Brittney L.
    Sirak, Bradley
    Martin-Gomez, Laura
    Reich, Richard R.
    Abrahamsen, Martha
    Isaacs-Soriano, Kimberly
    Chung, Christine H.
    Giuliano, Anna R.
    PLOS ONE, 2021, 16 (07):
  • [28] Secretory leukocyte protease inhibitor (SLPI) in cancer pathophysiology: Mechanisms of action and clinical implications
    Zhang, Xiaohua
    Liu, Shan Shan
    Ma, Jingru
    Qu, Wei
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 248
  • [29] Secretory leukocyte protease inhibitor (SLPI):: Oxidation of SLPI does not explain its variable anti-HIV activity
    Konopka, K
    Shine, N
    Pretzer, E
    Düzgünes, N
    JOURNAL OF DENTAL RESEARCH, 1999, 78 (12) : 1773 - 1776
  • [30] Secretory leukocyte protease inhibitor (SLPI) promotes cancer by preventing degradation of the growth-and survival factor progranulin (PRGN)
    Devoogdt, Nick
    Rasool, Nabila
    Simpkins, Fiona
    Cohen, Joshua
    Tchabo, Nana
    Revets, Hilde
    Ghassabeh, Gholamreza Hassanzadeh
    Kohn, Elise
    De Baetselier, Patrick
    ACTA CLINICA BELGICA, 2008, 63 (01): : 48 - 48
12345